CVS Health Upends the Diabetes Drug Market

CVS Health Upends the Diabetes Drug Market. A diabetic individual self-administering a dose of insulin to belly using a syringe.With rising prices for insulin and the costs of many other diabetes-related drugs taking their toll on patients, CVS Health recently announced that its pharmacy benefits management unit CVS Caremark is launching a program to enable employers and payers to offer these medications at no out-of-pocket costs to members.

The RxZERO program does not raise the costs for the plan sponsor or increase premiums or deductibles for plan members, CVS says. The move is expected to ensure long-term affordability, improve medication adherence and put patients on a path to better health.

The program relies on drug-formulary and plan-design approaches to eliminate patient co-pays across all categories of diabetes medications, including insulin and oral type 2 medications. The solution is detailed in a CVS Health white paper, “A Prescription for Better Diabetes Management.”

AHA Center for Health Innovation logo

Related Resources

Action Alert
Urge Your Representative to Cosponsor Surprise Medical Billing Legislation Approved by the House Ways and Means Committee The House returns to Washington, D.…
AHA Center for Health Innovation Market Scan
*/ /*-->*/ Spurring innovation has become a cornerstone of the AHA’s efforts to support hospitals and health systems as they continue transforming care…
AHA Center for Health Innovation Market Scan
*/ /*-->*/ Snapchat, the popular social website, is ready to test its reach in health care. The company will launch a new set of tools and custom content…
Advancing Health Podcast
On this podcast, Jay Bhatt, D.O., AHA senior vice president and chief medical officer, and Andy Shin, chief operating officer of the AHA Center for Health…
AHA Center for Health Innovation Market Scan
*/ /*-->*/ Payers and providers don’t always move at the same pace or have the same priorities when it comes to transforming health care. And if…
AHA Center for Health Innovation Market Scan
*/ /*-->*/ If you continue building, will they still come? In a nutshell, that’s what some analysts wanted Humana Inc. President and CEO Bruce Broussard…